Cipla submits application with USFDA for generic version of asthma drug
Drug major Cipla on Monday said it has submitted an application with
the US health regulator for a generic version of GSK's Advair Diskus,
which is used in the treatment of asthma and other respiratory
disorders.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-submits-application-with-usfda-for-generic-version-of-asthma-drug/articleshow/75798947.cms
the US health regulator for a generic version of GSK's Advair Diskus,
which is used in the treatment of asthma and other respiratory
disorders.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-submits-application-with-usfda-for-generic-version-of-asthma-drug/articleshow/75798947.cms
Comments
Post a Comment